Big Cypress Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $115.00M |
|---|---|
| IPO Date | Jan 12, 2021 |
| CEO | Samuel J. Reich |
| Left Lead | Ladenburg Thalmann |
| IPO Cash in Trust | 101.0% |
| SPAC Tenor | 15+(3*2) |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | SAB Biotherapeutics |
| Deal Announced | Jun 22, 2021 |
| Deal Size, $M | $325.38M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Oct 20, 2021 |
| Amendment Vote | TBD |
| Closing Date | Oct 22, 2021 |
Formerly BCYP
SABS
SABSW
| Price | $1.68 $0.17 |
|---|---|
| Last closing price | $1.75 |
| H/L, today | $1.64 / $1.78 |
| H/L, 52-week | $0.37 / $1.45 |
| Volume, today | 11,598 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.